Rohan Kalyan Rej

14PUBLICATIONS
19CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMedical molecular engineering of nucleic acids and proteinsMedical devicesElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 23, 2026
Discovery of SMD-6346: A Potent, Selective, and Orally Active SMARCA2 Degrader for Targeting SMARCA4-Deficient Human Cancers.

|Mar 23, 2026
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader.

Dimin Wu, Haibin Zhou, Longchuan Bai

|Jan 10, 2026
An Update on Clinically Advanced PROTAC Degraders and Their Synthesis.

Ranjan Kumar Acharyya, Yugandhar Kothapalli, Suresh Yarlagadda

|May 14, 2025
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast Cancer.

Guozhang Xu, Courtney G Havens, Qiaolin Deng

|May 01, 2025
Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy.

Zhixiang Chen, Harshil Dhruv, Xuqing Zhang

|Apr 08, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer".

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

Pageof 3

Frequent Collaborators

11 joint publications

Shaomeng Wang

8 joint publications

Duxin Sun

7 joint publications

Ranjan Kumar Acharyya

6 joint publications

Jelena Tošović